DarioHealth Corp. Payments To Acquire Equity Securities Fv Ni
DarioHealth Corp. (DRIO) reported Payments To Acquire Equity Securities Fv Ni of $9.25 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireEquitySecuritiesFvNi · last filed 2026-08-11
- DarioHealth Corp. payments to acquire equity securities fv ni for the quarter ending 2026-06-30 was $4.25M.
- DarioHealth Corp. payments to acquire equity securities fv ni for the quarter ending 2026-03-31 was $5.00M.
- DarioHealth Corp. payments to acquire equity securities fv ni for the quarter ending 2023-12-31 was $0.00.
- DarioHealth Corp. payments to acquire equity securities fv ni for the quarter ending 2023-09-30 was $0.00.
- DarioHealth Corp. payments to acquire equity securities fv ni for fiscal 2025 was $4.20M.
- DarioHealth Corp. payments to acquire equity securities fv ni for fiscal 2023 was $5.00M.
| Period end | Payments To Acquire Equity Securities Fv Ni 3 month | Payments To Acquire Equity Securities Fv Ni 6 month | Payments To Acquire Equity Securities Fv Ni 9 month | Payments To Acquire Equity Securities Fv Ni 12 month |
|---|---|---|---|---|
| 2026-06-30 | $4.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $9.25M 10-Q · filed 2026-08-11 | ||
| 2026-03-31 | $5.00M 10-Q · filed 2026-05-13 | |||
| 2025-12-31 | $4.20M 10-K · filed 2026-03-19 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | $0.00 derived: sum of 2 quarters · filed 2025-03-10 | $0.00 derived: sum of 3 quarters · filed 2025-03-10 | $5.00M 10-K · filed 2025-03-10 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $0.00 derived: sum of 2 quarters · filed 2024-11-07 | $5.00M 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $5.00M 10-Q · filed 2024-08-08 | ||
| 2023-03-31 | $5.00M 10-Q · filed 2024-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |